pyridazine has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bragstad, K; Goto, M; Hamada, T; Hori, Y; Itono, S; Kaieda, A; Kawamoto, T; Miwatashi, S; Miyazaki, T; Okada, K; Sang, BC; Shirasaki, M; Snell, G; Takagi, T; Takahashi, M; Takai, T; Tanaka, T; Uchikawa, O; Unno, S | 1 |
| Ashida, Y; Fukuda, S; Gyoten, M; Kamei, T; Kawano, Y; Midoro, K; Nagaya, H | 1 |
2 other study(ies) available for pyridazine and Disease Models, Animal
| Article | Year |
|---|---|
Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Cell Line; Disease Models, Animal; Drug Design; Enzyme Activation; Female; Humans; Molecular Dynamics Simulation; Monocytes; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyridazines; Rats; Rats, Inbred Lew; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2018 |
Inhibition of allergic dermal inflammation by the novel imidazopyridazine derivative TAK-427 in a guinea pig experimental model of eczema.
Topics: Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Dermatitis, Allergic Contact; Dexamethasone; Disease Models, Animal; Eczema; Female; Guinea Pigs; Histamine H1 Antagonists; Imidazoles; Male; Pyridazines; RNA, Messenger | 2002 |